InvestorsHub Logo
Followers 19
Posts 399
Boards Moderated 0
Alias Born 04/15/2008

Re: mick post# 8196

Tuesday, 06/07/2022 7:16:22 PM

Tuesday, June 07, 2022 7:16:22 PM

Post# of 8504
good to see the advisory board recommend approval by the FDA. We've needed an alternative to Mrna. It's been quite a rollercoaster with NVAX. Lot of shorts, expect some shenanigans along the way. Would think the guidance of 4-5B in revenues for 2022 looks good. Low P/E and small float could lead to some fireworks. Wouldn't be surprised to see a buyout.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVAX News